Showing results (151-160 of 165) with videos related to
Sort By:
Pageof 17
Iscience|May 30, 2023
Adipolin protects against renal injury via PPARα-dependent reduction of inflammasome activationLixin Fang, Koji Ohashi, Satoko Hayakawa, et al.Journal of Medicinal Chemistry|August 17, 2019
Development of the First Low Nanomolar Liver Receptor Homolog-1 Agonist through Structure-guided DesignSuzanne G Mays, Autumn R Flynn, Jeffery L Cornelison, et al.Proceedings of the National Academy of Sciences of the United States of America|April 12, 2012
Bax regulates primary necrosis through mitochondrial dynamicsRussell S Whelan, Klitos Konstantinidis, An-Chi Wei, et al.Circulation Research|June 15, 2022
Mitochondrial H2S Regulates BCAA Catabolism in Heart FailureZhen Li, Huijing Xia, Thomas E Sharp, et al.Circulation|July 2, 2016
Leukocyte-Expressed β2-Adrenergic Receptors Are Essential for Survival After Acute Myocardial InjuryLaurel A Grisanti, Anna M Gumpert, Christopher J Traynham, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 22, 2021
LPL/AQP7/GPD2 promotes glycerol metabolism under hypoxia and prevents cardiac dysfunction during ischemiaSohta Ishihama, Satoya Yoshida, Tatsuya Yoshida, et al.Journal of the American Society of Nephrology : JASN|July 30, 2014
Cardiac myocyte-derived follistatin-like 1 prevents renal injury in a subtotal nephrectomy modelSatoko Hayakawa, Koji Ohashi, Rei Shibata, et al.Cell Chemical Biology|March 22, 2022
A phospholipid mimetic targeting LRH-1 ameliorates colitisSuzanne G Mays, Emma H D'Agostino, Autumn R Flynn, et al.Proceedings of the National Academy of Sciences of the United States of America|February 12, 2014
Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthase-nitric oxide dependentAdrienne L King, David J Polhemus, Shashi Bhushan, et al.Angiogenesis|July 8, 2022
Therapeutic angiogenesis for patients with no-option critical limb ischemia by adipose-derived regenerative cells: TACT-ADRC multicenter trialYuuki Shimizu, Kazuhisa Kondo, Ryo Hayashida, et al.Pageof 17